Given the heterogeneity of breast cancer, the present identification of Wnt5a as a potential prognostic biomarker and an indicator of novel future therapies that might aid in further improving the survival of pre menopausal patients with ER+ breast cancers. The gene discussed is WNT5A; the disease is breast cancer.